-
Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2 Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Beatrice Ginman, Simon Pahnke, Eva Freyhult, Tove Hoffman, Linda Kolstad, Bengt Rönnberg, Åke Lundkvist, Kerstin Hamberg Levedahl, Gunilla Enblad, Ingrid Glimelius
Swedish recommendations to reduce the risk of COVID-19 relied on each citizen’s own sense of responsibility rather than mandatory lockdowns. We studied how COVID-19-related self-isolation and anxie...
-
Comparison of cutaneous adverse events between second-generation tyrosine kinase inhibitors and imatinib for chronic myeloid leukemia: a systematic review and meta-analysis Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Seung-Hyeon Cha, Kyungim Kim, Yun-Kyoung Song
Patients with chronic myeloid leukemia (CML) treated with tyrosine kinase inhibitors (TKIs) often experience cutaneous adverse events, such as rashes and pruritus. In this study, we aimed to compar...
-
The effect of a smoking cessation program for patients in cancer treatment: a quasi-experimental intervention study Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Elisabeth Kvaavik, Maja Weemes Grøtting, Torleif Halkjelsvik, Rene van Helvoirt, Ingeborg Hjertvik Kirkhorn, Maria Moksnes Bjaanes, Hanne Tøndel, Julia Thue Sværen, Helga Gripsgård, Kristin Byrkje, Arnfinn Helleve
Compared to non-smokers, smokers have reduced effects of cancer treatment, and increased risk of treatment-related toxicity. Quitting smoking can improve treatment effects and reduce side effects. ...
-
Pregnancy outcomes in female survivors of neuroblastoma: a short report from the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Arezo Azizi, Filippa N. Norsker, Marietta Kokla, Thomas T. Nielsen, Anna S. Holmqvist, Ingrid Øra, Kim Vettenranta, Hilde Øfstaas, Henrik Hasle, Catherine Rechnitzer, Jeanette F. Winther, Line Kenborg
Published in Acta Oncologica (Vol. 62, No. 12, 2023)
-
Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Christina Egnell, Helene Hallböök, Mats Heyman, Ulla Wartiovaara-Kautto, Petter Quist-Paulsen, Kjeld Schmiegelow, Laimonas Griskevicius, Katrin Palk, Nina Toft, Ulrik Malthe Overgaard, Arja Harila, Susanna Ranta
Data on outcome for patients in different body mass index (BMI) categories in young adults with acute lymphoblastic leukemia (ALL) are scarce. We explored survival and toxicities in different BMI c...
-
The impact of implementing current treatment modalities and female sex on gastric cancer outcomes, 2000–2016: a longitudinal nationwide cohort study Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Panu Aaltonen, Harri Mustonen, Katriina Peltola, Olli Carpén, Pauli Puolakkainen, Caj Haglund, Malin Sund, Hanna Seppänen
The implementation of current treatment modalities and their impact on nationwide gastric cancer outcomes remain poorly understood. Biological differences between females and males could impact sur...
-
ctDNA-guided adjuvant treatment after radical-intent treatment of metastatic spread from colorectal cancer—the first interim results from the OPTIMISE study Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Louise Bach Callesen, Torben Frøstrup Hansen, Rikke Fredslund Andersen, Niels Pallisgaard, Stine Kramer, Sven Schlander, Søren Rafael Rafaelsen, Anders Kindberg Boysen, Lars Henrik Jensen, Anders Jakobsen, Karen-Lise Garm Spindler
Patients with detectable ctDNA after radical-intent treatment of metastatic spread from colorectal cancer (mCRC) have a very high risk of recurrence, which may be prevented with intensified adjuvan...
-
Large scale experience of two ultrahypofractionated 5 fractions regimes after breast conserving surgery from a single centre Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Louis-Marie Sauvage, Pierre Loap, Jeremi Vu-Bezin, Kim Cao, Manon Kissel, Solène Bringer, Safia Maraadji, Alain Fourquet, Youlia Kirova
Ultra-hypofractionation breast radiotherapy is a safe alternative to moderate hypofractionation. This study reports the results of two ultrahypofractionated regimens used in clinical practice in a ...
-
Does the ypTNM-stage adequately predict long-term survival rates in gastric cancer patients receiving neoadjuvant chemotherapy followed by radical resection? Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Alina Desiree Sandø, Jon Erik Grønbech, Erling Audun Bringeland
Following neoadjuvant chemotherapy (NAC) for resectable gastric cancer, the prognostic adequacy of the UICC staging system needs to be investigated. In particular to explore whether the ypTNM curve...
-
Overall survival in 92,991 colorectal cancer patients in Germany: differences according to type of comorbidity Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Oliver Riedel, Jost Viebrock, Ulrike Haug
Poorer survival in cancer patients with vs. without comorbidity has been reported for various cancer sites. For patients with colorectal cancer (CRC), limited data are available so far.Patients wit...
-
Choose the healthy way! Physical activity as a tool to improve mental health in young cancer survivors Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Ambra Gentile, Salvatore Ficarra, Sonia Ortega-Gómez, David Jiménez-Pavón, Zoi Asimakopoulou, Apostolos Vantarakis, Paula Tavares, Vasco Vaz, Joshua Thaller, Sofia Papakonstantinou, Musa Kirkar, Francesca Glorioso, Marina Galioto, Mario Lo Mauro, Antonino Bianco
Published in Acta Oncologica (Vol. 62, No. 12, 2023)
-
Comparison between Swedish EORTC QLQ-C30 general population norm data published in 2000 and 2019 Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Hemming Johansson, Pernilla Lagergren, Sandra Nolte, Yvonne Brandberg
Normative health-related quality of life (HRQoL) data from the general population are regularly used to facilitate the interpretation of HRQoL as reported by cancer patients participating in cancer...
-
Prevalence and predictors for fertility-related distress among 1010 young adults 1.5 years following cancer diagnosis – results from the population-based Fex-Can Cohort study Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Kenny A. Rodriguez-Wallberg, Johan Ahlgren, Karin E. Smedby, Jessica R. Gorman, Kristina Hellman, Roger Henriksson, Olof Ståhl, Lena Wettergren, Claudia Lampic
Cancer treatment during reproductive ages may negatively impact fertility and there is a need of firm knowledge about the prevalence and predictors of fertility-related distress. The aim was to exa...
-
Most common health problems in general practice among adolescents, and young adults’ survivors of lymphoma: a register-based cohort study in Norway Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Ram Prasad Upreti, Elia Mmbaga, Hege Sagstuen Haugnes, Cecilie E. Kiserud, Ruby Del Risco Kollerud
The aim was to investigate the distribution of health problems in general practice (GP) among adolescent and young adult (AYA) survivors of lymphoma and to compare problem rates with the general po...
-
The association of having a monitoring or blunting coping style with psychological distress, health-related quality of life and satisfaction with healthcare in gastrointestinal stromal tumour (GIST) patients Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Deborah van de Wal, Britt van Doorn, Dide den Hollander, Ingrid M. E. Desar, Hans Gelderblom, Astrid W. Oosten, Anna K. L. Reyners, Neeltje Steeghs, Winette T. A. van der Graaf, Olga Husson
There are two main coping styles regarding information seeking under medical threat; monitoring (information-seeking) and blunting (information-avoiding). The aim of this study is to (1) determine ...
-
Predictors of preparedness for recovery following colorectal cancer surgery: a latent class trajectory analysis Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Richard Sawatzky, Cecilia Larsdotter, Eva Carlssson, Monica Pettersson, Elisabeth Kenne Sarenmalm, Frida Smith, Jonas Nygren, Lara Russell, Joakim Öhlén
With an interest in providing knowledge for person-centred care, our overall goal is to contribute a greater understanding of diversity among patients in terms of their preparedness before and up t...
-
Initial investigation of using Norwegian health data for the purpose of external comparator arms - an example for non-small cell lung cancer Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Siri Børø, Steinar Thoresen, Simon Boge Brant, Åslaug Helland
Using real-world (RW) data from registries to mimic or substitute a comparator arm of clinical trials is increasingly investigated. The feasibility of using data sources for this purpose depends on...
-
Prevalence of human papillomavirus (HPV) types 16 and 18 in cervical cancer in Stockholm, Sweden during 2019–2023 compared to 2003–2008 Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Lars Sivars, Stefan Holzhauser, Torbjörn Ramqvist, Emma Tham, Kristina Hellman, Tina Dalianis
The prevalence of different HPV types, especially HPV16 and 18 in cervical cancer in patients diagnosed 2019–2023 in Stockholm was compared to corresponding data from 2003–2008 before the introduct...
-
Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005–2017 Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Mette K. Thomsen, Katrine B. Løppenthin, Pernille E. Bidstrup, Elisabeth W. Andersen, Susanne Dalton, Lone N. Petersen, Helle Pappot, Christiane E. Mortensen, Mikkel B. Christensen, Anne Frølich, Ulrik Lassen, Christoffer Johansen
Concurrent chronic diseases and treatment hereof in patients with cancer may increase mortality. In this population-based study we examined the individual and combined impact of multimorbidity and ...
-
Opium use and risk of colorectal cancer: a multi-center case-referent study in Iran Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Maryam Hadji, Maryam Marzban, Hamideh Rashidian, Ahmad Naghibzadeh-Tahami, Mahin Gholipour, Elham Mohebbi, Roya Safari-Faramani, Monireh Sadat Seyyedsalehi, Bayan Hosseini, Reza Alizadeh-Navaei, Abbas Rezaianzadeh, Abdolvahab Moradi, Soodabeh ShahidSales, Farid Najafi, Vahid Moazed, Ali Akbar Haghdoost, Afarin Rahimi-Movaghar, Arash Etemadi, Reza Malekzadeh, Paolo Boffetta, Elisabete Weiderpass, Farin
Opium use has been associated with an increased risk of cancers of the lung, oesophagus, and pancreas, and it was recently classified by the International Agency for Cancer Research as carcinogenic...
-
Accuracy of Essential TNM to stage large colorectal (T3/T4) cancers in absence of nodal status information Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Marion Piñeros, James Brierley, Enrique Barrios, Patricia Cueva, Carina Musetti, Constanza Pardo, Kevin Ward, D. Maxwell Parkin
Published in Acta Oncologica (Vol. 62, No. 12, 2023)
-
Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer EGFR Exon 20 insertion mutations after platinum-based chemotherapy Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Tae Min Kim, Nicolas Girard, Grace Kah Mun Low, Jianmin Zhuo, Dae Young Yu, Yishen Yang, Maiko Murota, Cindy Thiow Koon Lim, Nora J. Kleinman, Byoung Chul Cho
In the single-arm CHRYSALIS trial, advanced non-small cell lung cancer patients harboring epidermal growth factor receptor (EGFR) exon 20 insertion (Exon 20ins) showed durable responses to amivanta...
-
Time trends in systemic treatment for patients with metastatic prostate cancer: a national cohort study Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Anne Holck Storås, Kaitlyn Tsuruda, Sophie Dorothea Fosså, Bettina Kulle Andreassen
Several new systemic treatments for primary metastatic prostate cancer patients (mPCa) were introduced in the last decade for both hormone-sensitive (mHSPC) and castration-resistant prostate cancer...
-
Diagnosis and treatment of breast cancer in Denmark during the COVID-19 pandemic: a nationwide population-based study Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Else Helene Ibfelt, Henry Jensen, Birgitte Vrou Offersen, Maiken Bang Hansen, Henrik Møller, Peer Christiansen, Tina Bech Olesen
The COVID-19 pandemic was a global health crisis with population-wide behavioural restrictions imposed worldwide to reduce transmission of infection and to limit the potential burden on the healthc...
-
STAT3-EphA7 axis contributes to the progression of esophageal squamous cell carcinoma Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Li Wang, Qiao-Feng Zhao, Bing-Bing Yang, Hui-Jie Liang, Xian-E Zhang, Xiao-Yan Zhang, Wan-Jing Yang, Zhi-Yu Guo, Xin Xu, Fang Tian, Qing-Hua Wu
Our previous study has revealed that EphA7 was upregulated in patient-derived esophageal squamous cell carcinoma (ESCC) xenografts with hyper-activated STAT3, but its mechanism was still unclear.To...
-
Clinical outcomes of ALK+ non-small cell lung cancer in Denmark Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Karin Holmskov Hansen, Jakob Sidenius Johansen, Edyta Maria Urbanska, Peter Meldgaard, Peter Hjorth-Hansen, Charlotte Kristiansen, Miroslaw Stelmach, Eric Santoni-Rugiu, Maiken Parm Ulhøi, Anders Bondo Dydensborg, Christina Dünweber, Jon Lykkegaard Andersen
Real-world clinical outcomes of anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC) patients vary. This study aimed to investigate the treatment and clinical outcomes of a...
-
Script-based automatic radiotherapy planning for cervical cancer Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Marit Funderud, Ingvild Straumsheim Hoem, Marte Anette Dunseth Guleng, Monika Eidem, Sigrun Saur Almberg, Mirjam Delange Alsaker, Josefine Ståhl-Kornerup, Jomar Frengen, Anne Beate Langeland Marthinsen
This study aimed to develop fully automated script-based radiotherapy treatment plans for cervical cancer patients, and evaluate them against clinically accepted plans, as validation before clinica...
-
Real-world analysis of MET exon 14 mutations in non-small cell lung cancer: a retrospective study from two Swedish hospitals Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Marcus Skribek, Hans Brunnström, Gudrun Oskarsdottir, Mikel Portu Grivé, Ozan Aricak, Maria Planck, Kenbugul Jatta, Homeyra Naserhojati, Felix Haglund de Flon, Simon Ekman
Real-World evidence on mesenchymal-epithelial transition exon 14 skipping mutations (METex14) in lung cancer remains limited. With an incidence of 3–4% across histological subtypes, METex14 is now ...
-
Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Tiago M. Bonde, Hans Garmo, Pär Stattin, Per Nilsson, Adalsteinn Gunnlaugsson, Daniela Swanberg, David Robinson
Oncological outcome after radical radiotherapy (RRT) combined with neoadjuvant and adjuvant androgen suppression therapy (AST) may differ according to type of AST. The aim of this nationwide regist...
-
Cumulative incidence of first recurrence after curative treatment of stage I–III colorectal cancer. Competing risk analyses of temporal and anatomic patterns Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Per Even Storli, Rachel Genne Dille-Amdam, Gaute Havik Skjærseth, Mads Vikhammer Gran, Tor Åge Myklebust, Jon Erik Grønbech, Erling A. Bringeland
Updated knowledge about the rates of recurrence and time to recurrence following curative treatment of colorectal cancer is essential to secure better patient information on prognosis, to serve as ...
-
Clinical implication of genetic intratumor heterogeneity for targeted therapy in head and neck cancer Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Signe Buhl Gram, Daniela Alosi, Frederik Otzen Bagger, Olga Østrup, Christian von Buchwald, Jeppe Friborg, Irene Wessel, Ivan Richter Vogelius, Kristoffer Rohrberg, Jacob Høygaard Rasmussen
Genomic profiling is increasingly used both in therapeutic decision-making and as inclusion criteria for trials testing targeted therapies. However, the mutational landscape may vary across differe...
-
Pathology of MRI and second-look ultrasound detected multifocal breast cancer Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Shu Su, Jason C. Ray, Corinne Ooi, Manish Jain
Targeted second-look ultrasound (US) is often performed following MRI of the breast to determine if an MRI-detected lesion is visible on US and thus amenable to US-guided biopsy. This study aimed t...
-
Treatment outcomes of non-small cell lung cancers treated with EGFR tyrosine kinase inhibitors: a real-world cohort study Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Otto Manninen, Laura Puuniemi, Sanna Iivanainen, Martti Arffman, Riitta Kaarteenaho, Jussi P. Koivunen
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) are a standard of care treatment options in non-small cell lung cancer (NSCLC). The present study investigated real-world EG...
-
Evaluation of tumor-infiltrating lymphocytes and mammographic density as predictors of response to neoadjuvant systemic therapy in breast cancer Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Amalia H. Landén, Kian Chin, Anikó Kovács, Erik Holmberg, Eva Molnar, Axel Stenmark Tullberg, Fredrik Wärnberg, Per Karlsson
Response rates vary among breast cancer patients treated with neoadjuvant systemic therapy (NAST). Thus, there is a need for reliable treatment predictors. Evidence suggests tumor-infiltrating lymp...
-
Active Breathing Coordinator reduces radiation dose to the stomach in patients with left breast cancer Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Ying Piao, Hongtao Chen, Fengshun Yuan, Juan Fan, Shihai Wu, Xianming Li, Dong Yang
Gastric dose parameters comparison for deep inspiration breath-hold (DIBH) or free breathing (FB) mode during radiotherapy (RT) for left-sided breast cancer patients (LSBCPs) has not been investiga...
-
Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Simon Schallenberg, Henning Plage, Sebastian Hofbauer, Kira Furlano, Sarah Weinberger, Paul Giacomo Bruch, Florian Roßner, Sefer Elezkurtaj, Martina Kluth, Maximilian Lennartz, Niclas C. Blessin, Andreas H. Marx, Henrik Samtleben, Margit Fisch, Michael Rink, Marcin Slojewski, Krystian Kaczmarek, Thorsten Ecke, Steffen Hallmann, Stefan Koch, Nico Adamini, Sarah Minner, Ronald Simon, Guido Sauter, David
Most inactivating p53 mutations result in a nuclear p53 accumulation – detectable by immunohistochemistry (IHC). p53 alterations leading to a complete lack of p53 protein and absence of immunostain...
-
Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Aino Siltari, Teemu J. Murtola, Josefina Kausz, Kirsi Talala, Kimmo Taari, Teuvo LJ. Tammela, Anssi Auvinen
Concerns have been expressed over the safety of testosterone replacement therapy (TRT) in men with late-onset hypogonadism (LOH). Previous studies have shown controversial results regarding the ass...
-
Evaluation of tumor-infiltrating lymphocytes, PD-L1, and PIK3CA mutations and association with prognosis in HER2-positive early stage breast cancer Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Frances M. Reznitsky, Jeanette D. Jensen, Ann Knoop, Maj-Britt Jensen, Anne-Vibeke Laenkholm
Tumor-infiltrating lymphocytes (TILs) have predictive and prognostic potential in HER2-positive breast cancer (HER2+ BC). Programmed death-ligand 1 (PD-L1) is an immune checkpoint protein, with imp...
-
Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and tolerability Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Ellen Backlund, Vitali Grozman, Suzanne Egyhazi Brage, Rolf Lewensohn, Karin Lindberg, Hildur Helgadottir
Radiotherapy (RT) is primarily considered as a palliative treatment in patients with metastatic melanoma. However, observations suggest that when RT is combined with immune checkpoint inhibitors (I...
-
Surgical decision-making following neoadjuvant immunotherapy for dMMR rectal cancer; case reports and review of the literature Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Mef Nilbert, Jakob Eberhard, Jenny Engdahl Severin, Marcus Edelhamre, Filip Torle, Dejan Korkocic, Fredrik Jörgren
Published in Acta Oncologica (Vol. 62, No. 12, 2023)
-
Ulcerative lymphomatoid papulosis following immune checkpoint inhibition and autologous stem cell transplant in a patient with recurrent Hodgkin lymphoma: a case report Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Lindsay M. Pattison, Mina Aziz, Mendel Goldfinger, Bijal Amin, Beth N. McLellan
Published in Acta Oncologica (Vol. 62, No. 12, 2023)
-
Vinorelbine thiotepa in metastatic breast cancer: a large real-life retrospective study Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Rebecca Loison, Baptiste Abbar, Leonor Drouin, Charlotte Bonnet-Bensimon, Caroline Cuvier, Sylvie Giacchetti, Marc Espie, Luis Teixeira, Victoire De Castelbajac
Published in Acta Oncologica (Vol. 62, No. 12, 2023)
-
Familial features affecting the melanoma risk in CDKN2A-negative melanoma families: a study based on the Swedish Cancer Registry Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Hildur Helgadottir, Karina Schultz, Jan Lapins, Veronica Höiom
Published in Acta Oncologica (Vol. 62, No. 12, 2023)
-
Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trial Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Simone Augustinus, Thijmen Broekman, Geert-Jan Creemers, Lois A. Daamen, Susan van Dieren, Jan-Willem B. de Groot, Geert A. Cirkel, Marjolein Y. V. Homs, Hanneke W. M. van Laarhoven, Lobke van Leeuwen, Maartje Los, Saskia A. C. Luelmo, Martijn G. H. van Oijen, Leontine E. A. M. Spierings, Judith de Vos-Geelen, Marc G. Besselink, Johanna W. Wilmink, for the Dutch Pancreatic Cancer Group
Published in Acta Oncologica (Vol. 62, No. 12, 2023)
-
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Morten Mau-Sørensen, Jonas Gerner-Rasmussen, Olfred Hansen, Bente Holm, Christa Haugaard Nyhus, Tine McCulloch, Henrik Anker Nielsen, Kim Wedervang, Carsten Rytter, Nina Jeppesen, Seppo W. Langer
Published in Acta Oncologica (Vol. 62, No. 12, 2023)
-
Evaluating video-based consultations in routine clinical practice at a comprehensive cancer center Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Thibaut Mottet, Victor Hémar, Sylvia Enfedaque, Simone Mathoulin-Pélissier, Hélène Charitansky, Yann Godbert, Guilhem Roubaud, Mathilde Cabart, Camille Chakiba, François Chomy, Laura Haik, Nicolas Le Dantec, Wafa Bouleftour, Nicolas Magné, Nathalie Quenel Tueux
Integrating telemedicine into cancer care remains a major challenge. There are little clinical evidence for teleconsultation efficacy and safety in daily oncology practice. This study as a pioneeri...
-
Treatment patterns, survival, and healthcare utilisation and costs in patients with locally advanced and metastatic bladder cancer in Denmark 2015–2020 Acta Oncol. (IF 3.1) Pub Date : 2023-11-25 Mette Nørgaard, Aurélie Mailhac, Karin Fagerlund, Torsten Strunz-McKendry, Mads Agerbæk, Jørgen Bjerggaard Jensen
Treatment patterns in locally advanced and metastatic urothelial bladder cancer (La/mUBC) is changing, but little is known about current treatment patterns, survival, and costs of these patients. O...
-
Geometric distortions in clinical MRI sequences for radiotherapy: insights gained from a multicenter investigation Acta Oncol. (IF 3.1) Pub Date : 2023-11-07 Signe Winther Hasler, Jesper Folsted Kallehauge, Rasmus Hvass Hansen, Eva Samsøe, Dennis Tideman Arp, Henrik Dahl Nissen, Jens M. Edmund, Uffe Bernchou, Faisal Mahmood
As magnetic resonance imaging (MRI) becomes increasingly integrated into radiotherapy (RT) for enhanced treatment planning and adaptation, the inherent geometric distortion in acquired MR images po...
-
Parameters for proton minibeam radiotherapy using a clinical scanning beam system Acta Oncol. (IF 3.1) Pub Date : 2023-11-07 Fardous Reaz, Mateusz Krzysztof Sitarz, Erik Traneus, Niels Bassler
Published in Acta Oncologica (Vol. 62, No. 11, 2023)
-
HPV testing versus p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: results from the DAHANCA 19 study Acta Oncol. (IF 3.1) Pub Date : 2023-11-07 Jacob Kinggaard Lilja-Fischer, Morten Horsholt Kristensen, Pernille Lassen, Torben Steiniche, Trine Tramm, Magnus Stougaard, Christian Maare, Jørgen Johansen, Hanne Primdahl, Claus Andrup Kristensen, Maria Andersen, Jesper Grau Eriksen, Jens Overgaard
The prognosis after primary (chemo-)radiotherapy for oropharyngeal squamous cell carcinoma (OPSCC) is affected by Human Papillomavirus (HPV) status, with a better prognosis in HPV-positive OPSCC. H...
-
Different benefits of adaptive radiotherapy for different histologies of NSCLC Acta Oncol. (IF 3.1) Pub Date : 2023-11-07 Marie Tvilum, Christina Maria Lutz, Marianne Marquard Knap, Lone Hoffmann, Azza Ahmed Khalil, Marianne Ingerslev Holt, Maria Kandi, Hjørdis Hjalting Schmidt, Ane L. Appelt, Markus Alber, Ditte S. Møller
Adenocarcinoma (AC) and squamous cell carcinoma (SCC) are the most frequent histological subtypes of non-small cell lung cancer (NSCLC). The aim of this study was to investigate how patients with A...
-
Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors Acta Oncol. (IF 3.1) Pub Date : 2023-11-07 Sofia Spampinato, Tiziana Rancati, Justyna Magdalena Waskiewicz, Barbara Avuzzi, Elisabetta Garibaldi, Adriana Faiella, Elisa Villa, Alessandro Magli, Domenico Cante, Giuseppe Girelli, Marco Gatti, Barbara Noris Chiorda, Luciana Rago, Paolo Ferrari, Cristina Piva, Maddalena Pavarini, Riccardo Valdagni, Vittorio Vavassori, Fernando Munoz, Giuseppe Sanguineti, Nadia Di Muzio, Kathrin Kirchheiner, Claudio
To evaluate the persistence of symptoms after radiotherapy (RT) for localised prostate cancer (PCa) and the association with quality of life (QOL).Prospective patient-reported outcome (PRO) from a ...
-
Treating brain metastases in metastatic breast cancer: outcomes after stereotactic radiosurgery examined in a retrospective, single-center cohort analysis Acta Oncol. (IF 3.1) Pub Date : 2023-11-07 Julie F. Depner, Tobias Berg, Bent Ejlertsen, Lærke W. Andreasen, Søren Møller, Maja V. Maraldo
We examined the role of receptor profiles and other prognostic factors in survival outcomes after stereotactic radiosurgery (SRS) for brain metastases in breast cancer patients, to help improve sel...
-
Dose-accumulation analysis of target and organs at risk with clinical outcome after re-irradiation of diffuse midline glioma Acta Oncol. (IF 3.1) Pub Date : 2023-11-07 Daniella Elisabet Østergaard, Isak Wahlstedt, Morten Jørgensen, Mimi Kjærsgaard, Rene Mathiasen, Karsten Nysom, Astrid Sehested, Ivan Richter Vogelius, Maja Vestmø Maraldo
Published in Acta Oncologica (Vol. 62, No. 11, 2023)
-
New technologies from bench to bedside - report from the Nordic association for clinical physics 2023 symposium. Acta Oncol. (IF 3.1) Pub Date : 2023-11-07 Stine Sofia Korreman,Claus Preibisch Behrens,Vibeke Nordmark Hansen,Jesper Thygesen,Thomas Lund Andersen
-
Co-occurrence of symptoms after radiochemotherapy in locally advanced cervix cancer patients: a cluster analysis Acta Oncol. (IF 3.1) Pub Date : 2023-11-07 Marta Pelizzola, Kari Tanderup, Supriya Chopra, Ina M. Jürgenliemk-Schulz, Remi Nout, Kathrin Kirchheiner, Sofia Spampinato
State of the art combined radiochemotherapy and image-guided brachytherapy for locally advanced cervical cancer (LACC) has shown improved disease control and survival as well as a significant reduc...
-
Correction Acta Oncol. (IF 3.1) Pub Date : 2023-11-07
Published in Acta Oncologica (Vol. 62, No. 11, 2023)
-
Dose planning study of proton versus photon radiotherapy for head and neck squamous cell carcinoma of unknown primary in the primary and recurrent setting Acta Oncol. (IF 3.1) Pub Date : 2023-11-07 Anne Ivalu Sander Holm, Ulrik Vindelev Elstrøm, Signe Bergliot Nielsen, Kenneth Jensen
Patients with head and neck squamous cell carcinoma of unknown primary (HNCUP) are often treated with extensive radiotherapy (RT). Frequently, the bilateral nodal clinical target volume (nCTV) and ...
-
Prediction of dose-sparing by protons assessed by a knowledge-based planning tool in radiotherapy of brain tumours Acta Oncol. (IF 3.1) Pub Date : 2023-11-07 Bob Smulders, Liliana Stolarczyk, Klaus Seiersen, Ole Nørrevang, Bente Sommer Kristensen, Deborah Anne Schut, Karsten Thomsen, Yasmin Lassen-Ramshad, Morten Høyer, Aida Muhic, Anne Vestergaard
Published in Acta Oncologica (Vol. 62, No. 11, 2023)
-
Think big–think BiGART. The 21st Acta Oncologica Symposium—BiGART 2023 Acta Oncol. (IF 3.1) Pub Date : 2023-11-07 Jesper Grau Eriksen, Birgitte Vrou Offersen, Morten Høyer, Cai Grau, Jens Overgaard
Published in Acta Oncologica (Vol. 62, No. 11, 2023)